Skip to main content
. 2005 Oct;167(4):1093–1103. doi: 10.1016/S0002-9440(10)61198-4

Figure 4.

Figure 4

A: Determination of bi-allelic inactivation by direct sequence analysis of blood, R+ cells, and A+ cells. The mutation site is indicated by a vertical arrow. A+ cell sequencing revealed the mutation in TSC2 exon 18 at residue 2110. Representative PCR analysis of chromosome 16p13.3 microsatellite markers D16S3024 (B) and D16S3394 (C) in blood, R+ cells, and A+ cells.